Dr.K.S.Shadaksharappa Hall(A)
|
|
|
- Simon Price
- 6 years ago
- Views:
Transcription
1 Dr.K.S.Shadaksharappa Hall(A) 9.00 AM AM Cardiology-Update Advances in Management of PAH Dr.S.Ramakrishnan Dr.Sudha Vidya Sagar Is intervention still relevant in stable CAD? Dr.Shantanu Guha Dr.Prabha Adhikari AM AM Dr.Coelio Memorial lectureship in experimental Medicine-Oration Recent Cardio Vascular Mega Trials Dr.Sundeep Mishra Dr.Rafiq Mohd Experimental & Technical Innovation in Gastrointestinal Endoscopy Dr.Chandrasekar Seshadri AM AM Honor Lecture Osteoporosis: An evidence based approach Dr.Tanu Shweta Pandey AM PM Cardiology Coronary microvascular dysfunction: An update How did Fractional flow reserve( FFR) guided revascularization change my clinical practice?: cases based discussion Dr.(Prof)S.M.Mustafa Zaman Dr.S.Nagendra Boopathy Dr.Milind Y Nadkar Dr.Ravi Keerthi Dr.S.P.Yadav Dr.Harshad D Dr.Gandarbha Ray Dr.S.P.Sooch Dr.G.D.Ravindra Dr.Manoj Kumar PM-1.00 PM Award Session PRF Awards API Awards Disease modifying medications in systolic heart failure L-ornithine L-aspartate in acute overt hepatic encephalopathy: a randomized placebo controlled trial Immunological profile of Enteric Fever Role of serum Troponin-I in identifying left ventricular ejection fraction of Dr.Alok Sehgal Omesh Goyal Ashima Katyal Samuel Jebaram D Dr.Sujit Vasudevan Dr.Pritam Gupta Dr.Y.P.Munjal Dr.B.R.Bansode Dr.Mangesh Tiwaskar Dr.Milind Y Nadkar 1 J.N.Berry Award Prevalence of Carbapenamase-producing klebsiella pneumoniae blood stream infections in a tertiary care center Deepinder Singh 2 D.P.Basu Award Diastolic dysfunction and mortality in early severe sepsis and septic shock: a prospective, observational echocardiography study Anish Pabba 1 Judges Dr.M.P.S.Chawla Dr.M.Ravikeerthi
2 3 M.J.Shah Award Dr.K.S.Shadaksharappa Hall(A) Evaluation of loop-mediated Isothermal Amplification(LAMP) for Diagnosis of Amoebic Liver Abcess Dipti Handa 1 DR. VITHALRAO NADGOUDA BEST ALL INDIA ANNUAL THESIS AWARD Dr. Anup P. Khobragade Dr. Vadlamudi Aparna 1.30 PM onwards Valedictory Function
3 Dr.V.Parameshwara HALL(B) 9.00 AM AM Hypertension Reno vascular hypertension: Current status Dr.Puneet Rijhwani Dr.D.Ram ABPM in clinical settings Dr.Narayan Deogaonkar Dr.Samarjit Banik Grey areas in diagnosis and management of HTN Dr.Anita Jaiswal Dr.H.S.Pathak AM AM Miscelleneous Calcium channel blocker in the management of Hypertension: Current status Dr.D.P.Chakraborty Dr.R.K.Modi Unmet needs & current magnitude of CHF Dr.Suresh Pattad Dr.Rajendra Chhabra Management of Upper GI bleed in ACS on dual antiplatelets Dr.J.K.Mokta Dr.Jagjit Ahuja AM PM Hepatology Update Alcoholic liver disease in women Dr.B.S.Nagaraja Dr.B.K.Singh Cirrhosis of Liver:Beyond beta blocker & diuretics Dr.Anup K Das Dr.K.D.Sharma Hepatorenal syndrome: Clinical considerations Dr.(Mrs)Tanuja Manohar Dr.Krishna Sen PM-1.20 PM Endocrinology Growth hormone replacement therapy: Current recommendations Dr.Minal Mohit(Jaipur) Dr.Sujeet Kumar Renal stone disease:endocrinologist perspective Dr.Vageesh Iyer Dr.Brijesh Pandey Hyperprolactenemia: How to manage? Dr.S.K.Sharma Dr.Sripad Dhanorkar Approach to a patient with Ptosis Dr.Anup Bhattacharya
4 Dr.T.B.Basavarajendra HALL(C) 9.00 AM AM Infections Dengue revisited Dr.V.Channaraya Dr.A.K.Virmani Malaria: Unusual complications Dr.YJV Reddy Dr.Uttam Pal Rickettsia infection spreading beyond boundaries Dr.Vasantha Kamath Dr.Peter George AM AM Misc Anemia in elderly: Experience at a large tertiary centre Dr.P.S.Ghalaut Dr.Uma Shankar Mishra Hemophilia in India: Recent advances Dr.Cecil Ross Dr.Manabendra Nayak Chronic energy deficiency: Association to NCD Dr.H.Basavangowdappa Dr.Thirupathi Rao AM PM Poisioning & Toxicology Snake Bite: Current guideline Dr.Shibendu Ghosh Dr.Angshuman Mukherjee Common poisioning & management Dr.Saurabh Srivastav Dr.V.Srinivas Reddy White Poisons in our diet & health hazards Dr.Subhash Giri Dr.Pravat Kumar PM-1.20 PM Cancer-Update Frailty:Current Concept Dr.Y.S.Raju Dr.T.K.Batabyal Immunotherapy a new weapon in cancer treatment Dr.Vineet Talwar Dr.Vijay Tundwal Targeted therapy in lung cancer Dr.Govinda Babu K Dr.Amartya Mishra Infection causing cancer Dr.Anupam Dey
5 Dr.H.S.Hande HALL(D) 9.00 AM AM Misc. Air ambulance service in India: Current scenario in 2018 Dr.Munish Prabhakar Dr.Prasanna Kumar Pesticides & chemicals as endocrine disruptors for obesity and metabolic syndrome: Recent evidence Dr.Arvind Gupta Dr.Veerendra Singh Noval therapies to preserve beta cell function Dr.Vijay Negalur Dr.Suresh Kanna AM AM Diabetes A decade of RCTs in diabetes: Clinical implication Dr.Suhas Erande Dr.E.Dhanda Pani Ambulatory glucose monitoring: mandatory or optional Dr.G.B.Sattur Dr.T.Yoganandh Management of Heat stroke Dr.Gautam Bhandari Dr.Harish Sidhwa AM PM Misc. Nocturia In elderly: A multidisciplinary approach Dr.Anish Kumar Gupta Dr.J.A.Vasanth Kumar ARDS:Recognition & management Dr.N.D.Karnik Dr.Ramlingam Management of acute Pancreatitis Dr.G.Loganathan Dr.K Manohar PM-1.20 PM HIV Ois in HIV: Changing scenario Dr.Amar Pazare Dr.Satish Mahajan HIV among elderly Dr.Swaroop K Baruah Dr.D.Ravi Vaccinations in HIV patients Dr.K.Ravi Dr.Thakur O.P.Singh Tropical Fever: A case based approach Dr.Manoranjan Behera
6 Dr.Basavaraje URS HALL(E) 9.00 AM AM Miscelleneous Nephrotic syndrome: Adult onset Dr.K.C.Gurudev Dr.Sanjay Kalra Lung fibrosis: An approach Dr.K.S.Satish Dr.P.Paranthaman Glycemic pentad: A comprehensive approach in diabetes management Dr.Neeta Deshpande Dr.C.S.Gauthaman AM AM Miscelleneous Challenges of obesity in women in India Dr.Sarita Behera Dr.T.Gurumurty Palliative care: Physicians perspective Dr.S.N.Sinha Dr.Packiyamary Management of diabetes in resource crunch countries Dr.G.Prakash Dr.Anish Gautam AM PM Miscelleneous Transfusion transmitted infections Dr.Apu Adhikari Dr.Ambika Mohanty Adult Immunization :Current scenario in India Dr.Prashanta Bhattacharya Dr.Sunil N.S. Refractory anemia: What to do? Dr.Ashish Dixit Dr.Mary Alias PM-1.20 PM Miscelleneous Self management and education: A noval tool for diabetes management Dr.Amit Gupta Dr.Tejas Prajapati Increatin therapy: Paradigm shift of T2DM Dr.Parixit Goswami Dr.Prabhat Agarwal Exercise prescription for life style diseases: A corner stone Dr.Anil Virmani Dr.M.S.Biradar Vaccines in adult HIV Dr.S.K.Guha
Dr.K.S.Shadaksharappa Hall(A)
Dr.K.S.Shadaksharappa Hall(A) 8.30 AM - 9.00 AM Inaugration of Scientific Program 9.00 AM- 9.30 AM Sanofi Aventis Lectureship in Diabetes Oration Can Medical Care Change the Natural History of T2DM: Turning
Dr.K.S.Shadaksharappa Hall(A)
Dr.K.S.Shadaksharappa Hall(A) 9.00 AM-10.00 AM Update Session Kalazar elemination in India Dr.Shyam Sunder Dr.S.K.Aggarwal Barrier in Insulin Therapy Dr.Amit Varma Dr.J.Sharanappa Dr.Amit Gupta DIC: Management
DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
Dr.K.S.Shadaksharappa Hall(1)
Dr.K.S.Shadaksharappa Hall(1) 8.30 AM - 9.00 AM Inaugration of Scientific Program 9.00 AM- 9.30 AM Can Medical Care Change the Natural History of T2DM: Turning Dr.Rajesh Rajput Dr.Siddharth N Shah Sanofi
Dr.K.S.Shadaksharappa Hall (1)
Dr.K.S.Shadaksharappa Hall (1) 9.00 AM-10.00 AM Update Session Kalazar elemination in India Dr.Shyam Sunder Dr.S.K.Aggarwal Rational use of antibiotics in ICU Dr.H.S.Pannu Dr.Amit Gupta DIC: Management
PROGRAMME AT A GLANCE
PROGRAMME AT A GLANCE Hotel Hyatt Andaz Hotel Pullman Date Hall-H1 Hall-H2 Hall-P1 Hall-P2 Hall-P3 Hall-P4 Hall-P5 Hall-P6 Basic science workshop 1 Basic Science Workshop 2 Postgraduate Course - Liver
Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
DEPARTMENT OF GENERAL MEDICINE WELCOMES
DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global
Andhra Pradesh, India Corresponding Author: Dr. S. Parveen *
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn:2278-3008, p-issn:2319-7676. Volume 12, Issue 6 Ver. II (Nov. Dec. 2017), PP 46-53 www.iosrjournals.org Efficacy And Tolerability Of
Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
Pattern of Use of Anti-Hypertensive Drugs In a North Indian Tertiary Care Hospital Renu, Hema Chhabra, Anita Gupta, Neetu Sharma
Original Article Pattern of Use of Anti-Hypertensive Drugs In a North Indian Tertiary Care Hospital 1 1 2 3 Renu, Hema Chhabra, Anita Gupta, Neetu Sharma 1 2 3 Junior Resident, Professor and Head, Assistant
Managing HTN in the Elderly: How Low to Go
Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular
Creighton University Internal Medicine Residency Curriculum Cycle of 33 months
Creighton University Internal Medicine Residency Curriculum Cycle of 33 months Cardiology: 13 lectures and once a month EKG lecture, 25 total 1. EKG interpretation Once a month 2. Heart failure: 2 lectures.
HALL-A. S.NO Time TYPE OF LECTURE SPEAKER TOPIC Chairperson AM TO 9.00 AM INAUGRATION OF CME DR.C.PRAKASH DR.UPENDRA KAUL(MODERATOR)
HALL-A S.NO Time TYPE OF LECTURE SPEAKER TOPIC Chairperson 1 8.30 AM TO 9.00 AM INAUGRATION OF CME DR.C.PRAKASH 2 9.00 AM TO 9.30 AM KEY NOTE ADDRESS DR.(PROF) ANAND MALAVIYA Managing Rheumatoid arthritis:-a
Gastrointestinal System: Accessory Organ Disorders
Gastrointestinal System: Accessory Organ Disorders Mary DeLetter, PhD, RN Associate Professor Dept. of Baccalaureate and Graduate Nursing Eastern Kentucky University Disorders of Accessory Organs Portal
Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines
Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict
Antialdosterone treatment in heart failure
Update on the Treatment of Chronic Heart Failure 2012 Antialdosterone treatment in heart failure 전남의대윤현주 Chronic Heart Failure Prognosis of Heart failure Cecil, Text book of Internal Medicine, 22 th edition
Congestive Heart Failure: Outpatient Management
The Chattanooga Heart Institute Cardiovascular Symposium Congestive Heart Failure: Outpatient Management E. Philip Lehman MD, MPP Disclosure No financial disclosures. Objectives Evidence-based therapy
A Study Conducted At A Tertiary Care Teaching Institute in Chennai, on The Clinical And Etiological Profile Of Patients With Acute Heart Failure.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 12 Ver. VIII (Dec. 2017), PP 27-33 www.iosrjournals.org A Study Conducted At A Tertiary Care
DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
Cardiorenal and Renocardiac Syndrome
And Renocardiac Syndrome A Vicious Cycle Cardiorenal and Renocardiac Syndrome Type 1 (acute) Acute HF results in acute kidney injury Type 2 Chronic cardiac dysfunction (eg, chronic HF) causes progressive
DAYANAND MEDICAL COLLEGE AND HOSPITAL, LUDHIANA MBBS Final Prof-II (Batch-2013)
Friday 01 Sept Obst & Rh - ve Saturday 02 Sept Central Complications of 3 rd stage of labour Sunday 03 Sept Monday 04 Sept Surgery Surgical Complications of Thyphoid Tuesday 05 Sept Surgery Surgical Complications
Diabetes and Hypertension
Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for
Antihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
tentative Scientific Programme (APICON 2018)
22 tentative Scientific Programme (APICON 2018) Friday, 23 rd February, 2018 Hall - A 8.30 am - 9.00 am Inaugration of Scientific Program Dr. Y.P. Munjal 9.00 am - 9.30 am Sanofi Aventis Lectureship in
Saturday, 30 th September 2017 WCCPCI-2017 HALL B
Saturday, 30 th September 2017 WCCPCI-2017 HALL B TIME TOPIC 9.00-10.15 am CLINICAL TRACK Chairpersons: Pawan Sharma (USA); A S Multani (Amritsar); Puneet Arora (Amritsar); Ravi Kant (Amritsar); Navneet
OF GERIATRIC MORBIDITY PATTERN AT TERTIARY CARE CENTER
International Journal of Medical Science and Education An official Publication of Association for Scientific and Medical Education (ASME) Original Research Article ASSESSMENT OF GERIATRIC MORBIDITY PATTERN
Index. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Activated partial thromboplastin time abnormality, perioperative approach to, 104 105 Acute kidney injury, perioperative, 89 99 early
egfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
OCHSNER PHYSICIAN PARTNERS. PQRS Measures by Specialty (FINAL)
OCHSNER PHYSICIAN PARTNERS PQRS Measures by Specialty (FINAL) Allergy and Immunology 2. Asthma: Pharmacologic Therapy for Persistent Asthma - Ambulatory Care Setting (PQRS 53) 3. Patients aged 18 years
Renal fractional flow reserve and hypertension response after renal artery stenting
Renal fractional flow reserve and hypertension response after renal artery stenting Jacek Kadziela,Adam Witkowski, Andrzej Januszewicz, Aleksander Prejbisz, Ilona Michałowska, Krzysztof Cedro, Magdalena
Updates & Controversies in Perioperative Medicine
Updates & Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Updates in Perioperative Medicine Estimating mortality in surgical
Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept
Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept Continents 1- introduction 2- classification/definition 3- classification/etiology 4-etiology in both categories 5- complications
HFpEF. April 26, 2018
HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
CLINICAL PRACTICE GUIDELINE
CLINICAL PRACTICE GUIDELINE Procedure: Congestive Heart Failure Guideline Review Cycle: Biennial Reviewed By: Amish Purohit, MD, MHA, CPE, FACHE Review Date: November 2014 Committee Approval Date: 11/12/2014
Therapeutic Targets and Interventions
Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium
Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
Patient characteristics Intervention Comparison Length of followup
ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing
The ACC 50 th Annual Scientific Session
Special Report The ACC 50 th Annual Scientific Session Part One From March 18 to 21, 2001, physicians from around the world gathered to learn, to teach and to discuss at the American College of Cardiology
Updates in Congestive Heart Failure
Updates in Congestive Heart Failure GREGORY YOST, DO JOHNSTOWN CARDIOVASCULAR ASSOCIATES 1/28/2018 Disclosures Edwards speaker on Sapien3 valves (TAVR) Stages A-D and NYHA Classes I-IV Stage A: High risk
DECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Is there a mortality risk associated with aspirin use in heart failure? Results from a large community based cohort Margaret Bermingham, Mary-Kate Shanahan, Saki Miwa,
SCOMPENSO CARDIACO: IL PUNTO DELLA RICERCA
Journal Club 19 Marzo 2010 SCOMPENSO CARDIACO: IL PUNTO DELLA RICERCA Alessandro Giordano Prevalence of heart failure by sex and age (NHANES:1999-2004) Circulation 2007 Incidence of heart failure by age
Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study
Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Dr. Antonio Magaña M.D. (on behalf I-PREFER investigators group) Stockholm, Sweden, August
Heart Failure. Guillaume Jondeau Hôpital Bichat, Paris, France
Heart Failure Guillaume Jondeau Hôpital Bichat, Paris, France Epidemiology Importance of PEF Europe I-PREFER study. Abstract: 2835 Prevalence of HF Preserved LV systolic Function older (65 vs 62 y, p
JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings
CMS-1345-P 174 Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings AIM: Better Care for Individuals 1. Patient/Care Giver Experience
Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure
Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
2010 ACLS Guidelines. Primary goals of therapy for patients
2010 ACLS Guidelines Part 10: Acute Coronary Syndrome Present : 內科 R1 鍾伯欣 Supervisor: F1 吳亮廷 991110 Primary goals of therapy for patients of ACS Reduce the amount of myocardial necrosis that occurs in
For The Critters Present
For The Critters Present Be sure to Sepsis Sepsis secondary to UTI Bacteremia SIRS secondary to infection For More Info-Contact Your Documentation Specialist Pat Spadaro, R.N. 6796 Rosanne Garofano, R.N.
Bell Ringer: Unit 5: Prevention & Control of Disease Lesson 1. types of diseases. risk. that suffers from a Non-Infectious Disease
Unit 5: Prevention & Control of Disease Lesson 1 Bell Ringer: 1. Define non-infectious disease (see vocab list) 2. List 5 things that put someone at risk for these types of diseases 3. List 5 things someone
ESC GUIDELINES ON DIABETES AND CARDIOVASCULAR DISEASES
ESC GUIDELINES ON DIABETES AND CARDIOVASCULAR DISEASES Pr. Michel KOMAJDA Institute of Cardiology - IHU ICAN Pitie Salpetriere Hospital - University Pierre and Marie Curie, Paris (France) DEFINITION A
Heart Failure with Preserved Ejection Fraction. April 4, 2018 Mike Muellerleile M.D.
Heart Failure with Preserved Ejection Fraction April 4, 2018 Mike Muellerleile M.D. Heart Failure with Preserved Ejection Fraction Introduction Clinical Description of HFpEF Pathophysiology of HFpEF
Intravenous Inotropic Support an Overview
Intravenous Inotropic Support an Overview Shaul Atar, MD Western Galilee Medical Center, Nahariya Affiliated with the Faculty of Medicine of the Galilee, Safed, Israel INOTROPES in Acute HF (not vasopressors)
Management of Cardiovascular Disease in Diabetes
Management of Cardiovascular Disease in Diabetes Radha J. Sarma, MBBS, FACP. FACC. FAHA. FASE Professor of Internal Medicine Western University of Health Sciences. Director, Heart and Vascular Center Western
Objectives. Let s start at the beginning 10/28/2014. What is Heart Failure? Understanding Heart Failure with Preserved LV Systolic Function
Understanding Heart Failure with Preserved LV Systolic Function Eric Ernst, MD Medical Director C.O.R.E. Clinic Objectives Clarify the terminology surrounding right heart failure and diastolic heart failure
HEART FAILURE IN WOMEN. Marian Limacher, MD Division of Cardiovascular Medicine University of Florida
HEART FAILURE IN WOMEN Marian Limacher, MD Division of Cardiovascular Medicine University of Florida Outline Epidemiology Clinical Overview Why HF is such a challenge State of the Field Heart Failure Adjudication
Study on admitted cases of complicated malaria in Government General Hospital, Guntur
Original article: Study on admitted cases of complicated malaria in Government General Hospital, Guntur 1Dr. T. V. Adi Seshu Babu, 2 Dr.Uday Shankar Sanakayala 1Associate professor, Department of General
National Horizon Scanning Centre. Irbesartan (Aprovel) for heart failure with preserved systolic function. August 2008
Irbesartan (Aprovel) for heart failure with preserved systolic function August 2008 This technology summary is based on information available at the time of research and a limited literature search. It
Ejection Fraction in Patients With Chronic Heart Failure. Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction
Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction Keith Miller MD Diastolic Heart Failure Risk Factors Common Risk Factors Aging Female gender Obesity Hypertension Diabetes mellitus
Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner
2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current
Going to high altitude with heart disease. Prof. Dr. med. Stefano Rimoldi High Altitude Medicine Inselspital Bern
Going to high altitude with heart disease Prof. Dr. med. Stefano Rimoldi High Altitude Medicine Inselspital Bern stefano.rimoldi@insel.ch There are very few studies on patients with heart disease going
Approach To Collagen vascular Dr. G.Narsimulu Disorders with Case Scenarios. Newer Oral Anti diabetic Drugs Dr. Sanjay Reddy.
ORGANISED BY PESIMSR KUPPAM PROGRAMME SCHEDULE FOR CME (07.09.2018) 8:30am-9:45am 9:45AM 10:00AM REGISTRATION FOR THE ENTIRE CONFERENCE AND BREAKFAST Inauguration of CME Chief Guest: Dr G. Narsimulu MD,
DIA LEAGUE DIA LEAGUE. 26 th November, Bhubaneshwar, India
26 th November, Bhubaneshwar, India : "The Dia League CME was held at Bhubaneswar under the banner of Asian Society of Continuing Medical Education. The CME was designed to get all the Diabetologist, Endocrinologist
Atrial Fibrillation and Heart Failure: A Cause or a Consequence
Atrial Fibrillation and Heart Failure: A Cause or a Consequence Rajat Deo, MD, MTR Assistant Professor of Medicine Division of Cardiology, Electrophysiology Section University of Pennsylvania November
Topic Page: congestive heart failure
Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation
Metoprolol Succinate SelokenZOC
Metoprolol Succinate SelokenZOC Blood Pressure Control and Far Beyond Mohamed Abdel Ghany World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014. 1 Death Rates From Ischemic
Management of chronic heart failure: pharmacology. Giuseppe M.C. Rosano, MD, PhD, FHFA
Management of chronic heart failure: pharmacology. Giuseppe M.C. Rosano, MD, PhD, FHFA Declaration of potential conflict of interests Type of job or financial support Salary Ordinary funds Position in
Life After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention
Life After CORAL: What Did CORAL Prove? David Paul Slovut, MD, PhD Co-director TAVR, Dir of Advanced Intervention No Relationships to Disclose The Need for Modern Renal Trials Increased rate of RAS diagnosis
Supplementary Table S1: Proportion of missing values presents in the original dataset
Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)
Fattori condizionanti la sopravvivenza nel paziente con scompenso di cuore
Journal Club 13 Febbraio 2008 Fattori condizionanti la sopravvivenza nel paziente con scompenso di cuore Intissar Sleiman Prevalence of heart failure by sex and age (NHANES:1999-2004) Circulation 2007
The ACC Heart Failure Guidelines
The ACC Heart Failure Guidelines Fakhr Alayoubi, Msc,R Ph President of SCCP Cardiology Clinical Pharmacist Assistant Professor At King Saud University King Khalid University Hospital Riyadh-KSA 2017 ACC/AHA/HFSA
Contents. 1. Setting-up an Adult Immunization Clinic 1 D Suresh Kumar, J Hemalatha. 2. Principles of Immunization 3 YP Munjal, Anupam Prakash, Manish
1. Setting-up an Adult Immunization Clinic 1 D Suresh Kumar, J Hemalatha Stepwise Approach in Setting Adult Immunization Clinic 1 2. Principles of Immunization 3 YP Munjal, Anupam Prakash, Manish Active
2016 Update to Heart Failure Clinical Practice Guidelines
2016 Update to Heart Failure Clinical Practice Guidelines Mitchell T. Saltzberg, MD, FACC, FAHA, FHFSA Medical Director of Advanced Heart Failure Froedtert & Medical College of Wisconsin Stages, Phenotypes
Pharmacological Treatment for Chronic Heart Failure. Dr Elaine Chau HK Sanatorium & Hospital, Hong Kong 3 August 2014
Pharmacological Treatment for Chronic Heart Failure Dr Elaine Chau HK Sanatorium & Hospital, Hong Kong 3 August 2014 1 ACC/AHA 2005 guideline update for Diagnosis & management of CHF in the Adult -SA Hunt
HYPERTENSION IN THE ELDERLY A BALANCED APPROACH. Barry Goldlist October 31, 2014
HYPERTENSION IN THE ELDERLY A BALANCED APPROACH Barry Goldlist October 31, 2014 DISCLOSURE I have not accepted any money for myself from any pharmaceutical company in the 21 st century I have accepted
Accidental Poisoning in Children At Tertiary Care Unit
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 6 Ver. XII (June. 2017), PP 61-65 www.iosrjournals.org Accidental Poisoning in Children At
Vitals HR 90 BP 125/58 Tmax 98.7F O2 Sat 97% on NC 2L/min BMP SCr 1.78 K 3.9 Gluc 194 A1c 7.5 Cardiac LVEF 55% NTproBNP 9,200 Troponin 0.
ALDOSTERONE ANTAGONIST IN HEART FAILURE WITH PRESERVED EJECTION FRACTION ABBREVIATIONS BMP: basic metabolic panel HPI: history of present illness CAD: coronary artery disease HR: heart rate PINHUI (JUDY)
TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**
Documentation and coding guide Disease definitions* HTN is diagnosed when the average of two or more (systolic of diastolic) blood pressure readings are found to be elevated on two or more office visits
Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema
Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema A.D. Margulescu 1,2, R.C. Sisu 1,2, M. Florescu 2,
Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
Drug treatments in hypertension outcome studies
The Second Australian National Blood Pressure Study Page 1 of 6 Background Outcome of treatment of hypertension Over the past 25 years studies of the drug treatment of mild-moderate hypertension have demonstrated
Summary/Key Points Introduction
Summary/Key Points Introduction Scope of Heart Failure (HF) o 6.5 million Americans 20 years of age have HF o 960,000 new cases of HF diagnosed annually o 5-year survival rate for HF is ~50% Classification
Heart Failure in 2012 with reference to NICE Guidance Dr Maurice Pye Consultant Cardiologist York District Hospital
Heart Failure in 2012 with reference to NICE Guidance 2010 Dr Maurice Pye Consultant Cardiologist York District Hospital A little over elaborate,do not include ECG or CXR If clinical suspicion is high
WOMEN S HEALTH FOR PRIMARY CARE. San Diego, California Hotel del Coronado August 10 13, 2017
WOMEN S HEALTH FOR PRIMARY CARE San Diego, California Hotel del Coronado August 10 13, 2017 Thursday, August 10th: 7:30 am 8:00 am Registration and Hot Breakfast 8:00 am 9:00 am Gynecology Abnormal Uterine
Diastolic Heart Failure
Diastolic Heart Failure Presented by: Robert Roberts, M.D., FRCPC, MACC, FAHA, FRSC Professor of Medicine and Chair ISCTR University of Arizona, College of Medicine Phoenix Scientist Emeritus and Advisor,
Echocardiographic study of left ventricular diastolic dysfunction in normotensive asymptomatic type II diabetes mellitus
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 7 Ver. VI (July. 2015), PP 39-43 www.iosrjournals.org Echocardiographic study of left ventricular
Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy
Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 7, 2012 VanderbiltHeart.com Outline
Day-1 (3 rd November 2018)
8.30 AM 9.30 AM Registration Day-1 (3 rd November 2018) Upper G Cancer 10.00 AM - 13.00 PM Session Part Time Topic Chairperson Moderator Speaker A 9.30 AM 9.50 AM G endoscopy and EUS Dr. J K Singh Dr.
Experience with 500 Stentless Aortic Valve Replacements
Experience with 500 Stentless Aortic Valve Replacements Dimitrios C. Iliopoulos, MD Cardiac Surgeon Ass. Professor of Surgery University of Athens, School of Medicine I declare no conflict of interest
Blood transfusions in ICU: double-edged sword. Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal
Blood transfusions in ICU: double-edged sword Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal Canadian Critical Care Trials Group Collaborating for Impact Leading
The Diabetes Link to Heart Disease
The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM
Supplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Olesen JB, Lip GYH, Kamper A-L, et al. Stroke and bleeding
SEROPREVALENCE OF ANTI-HCV ANTIBODIES AMONG VOLUNTARY BLOOD DONORS IN FATEHABAD DISTRICT OF HARYANA
SEROPREVALENCE OF ANTI-HCV ANTIBODIES AMONG VOLUNTARY BLOOD DONORS IN FATEHABAD DISTRICT OF HARYANA *Sangwan L., Arun P. 2 and Munjal A. 3 Haryana Civil Medical Service, Fatehabad, Haryana *Author for
DISCLOSURES ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION NONE
ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION Lori M. Tam, MD Providence Heart Institute DISCLOSURES NONE 1 OUTLINE Systolic vs. Diastolic Heart Failure New
econsult How to Guide for Specialty econsultants
econsult How to Guide for Specialty econsultants What You Will Learn Guideline for econsults Responding to an econsult request econsult Examples 2 Guideline for econsults Re-State the Question Define the
Antihypertensive Drugs Prescribing Pattern in Patients Attending to Medicine Outpatient Department
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 9 Ver. XIV (September. 2016), PP 53-57 www.iosrjournals.org Antihypertensive Drugs Prescribing
HTN talk_l Davis_ /28/2018
1 2 GUIDELINES PUBLISHED AHEAD OF PRINT NOV 13, 2017 = SAME DAY AS PUBLIC PRESENTATION LESLIE L DAVIS, PHD, RN, ANP-BC, FPCNA, FAANP, FAHA The New Guidelines Have Been Published! Whelton PK, Carey RM,